Tag: ESC 2017
ESC 2017: Further decreasing mortality after STEMI will be difficult
According to results from the FAST-MI programme, six-month mortality after ST-segment elevation ...
ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event
Of 5,691 adverse events following transcatheter aortic valve implantation (TAVI) that were repor...
ESC 2017: More evidence that supplemental oxygen in normoxic patients with suspected myocardial infarction does not provide benefit
Data from DET02X-AMI (Determination of the role of oxygen in suspected acute myocardial infarcti...
ESC 2017: Alternative strategies needed for treating stenotic lesions in saphenous vein grafts
The recent DIVA (Drug-eluting stents vs. bare metal stents in saphenous vein graft angioplasty) ...
ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in patients with type 1 diabetes
Data from a nationwide observational cohort study indicate that coronary artery bypass grafting (CAB...
ESC 2017: Young cardiologists discuss highlights of congress
In this video from the European Society of Cardiology (ESC), Steen Dalby Kristensen (Department of C...
ESC 2017: MobiusHD implant shown to reduce resistant hypertension
The European results of the first-in-human trial of Vascular Dynamics’ MobiusHD implant indicate...
ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and myocardial infarction in patients with coronary artery disease
The COMPASS study, which was presented at the European Society of Cardiology (ESC) congress (26–...
ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by 29% in patients with prior myocardial infarction
A new subanalysis from the phase III PEGASUS-TIMI 54 trial, which was presented at the European ...
ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome
During a late-breaking science session at the European Society of Cardiology (ESC) congress (26–...
ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de novo three-vessel disease
The SYNTAX II study has found that percutaneous coronary intervention (PCI) using state-of-the-a...
ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works
Results from SPYRAL HTN-OFF MED indicate that renal denervation, compared with a sham procedure,...
ESC 2017: Significantly lower event rates with Orsiro than with Xience
Results from the BIOFLOW V study indicate that patients who undergo percutaneous coron...
ESC 2017: Case builds for dropping aspirin from triple therapy in atrial fibrillation patients post PCI
The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoa...
